Guerbet SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guerbet SA with three other
companies in this sector in France:
sales of 617.54 million Euro [US$706.56 million]
of which 50%
was Non-Proprietary Homeopathic Medicines),
(352.17 million Euro [US$402.94 million]
of which 56%
was Europe), and
(861.88 million Euro [US$986.13 million]
of which 55%
was Companion Animals).
During the year ended December of 2017, sales at
Guerbet SA were 807.12 million Euro (US$923.47 million).
increase of 4.0%
versus 2016, when the company's sales were 775.77 million Euro.
This was the fourth straight year of sales growth at Guerbet SA.
Sales of Mri saw an increase
that was more than double the company's growth rate: sales were up
10.3% in 2017, from
246.70 million Euro to 272.00 million Euro.